Loading...
•
Mar 31, 2024
GE HealthCare Q1 2024 Earnings Report
GE HealthCare's financial performance in Q1 2024 showed a slight revenue decline but margin expansion, driven by productivity and pricing. The company reaffirmed its full-year guidance.
Key Takeaways
GE HealthCare reported a 1% decline in revenues, but organic revenue was approximately flat. Net income margin increased to 8.0%, and adjusted EBIT margin rose to 14.7%. Diluted EPS was $0.81, and adjusted EPS was $0.90. The company reaffirmed its full-year 2024 guidance.
Revenues declined 1% year-over-year, but organic revenue growth was approximately flat.
Net income margin increased to 8.0%, and adjusted EBIT margin rose to 14.7%.
Diluted EPS was $0.81, and adjusted EPS was $0.90.
Cash flow from operating activities was $419 million, and free cash flow was $274 million. Company reaffirmed full year 2024 guidance
GE HealthCare
GE HealthCare
GE HealthCare Revenue by Segment
Revenue by Segment
Imaging Revenue
CapyFin.comAdvanced Visualization Revenue
CapyFin.comPatient Care Solutions Revenue
CapyFin.comPharmaceutical Diagnostics Revenue
CapyFin.comOther Revenue
CapyFin.com Forward Guidance
The Company is reaffirming full year 2024 guidance as follows:
Positive Outlook
- Organic revenue growth of approximately 4% year-over-year.
- Adjusted EBIT margin in the range of 15.6% to 15.9%, reflecting an expansion of 50 to 80 basis points versus 2023 Adjusted EBIT margin of 15.1%.
- Adjusted effective tax rate (ETR) in the range of 23% to 25%.
- Adjusted EPS in the range of $4.20 to $4.35, representing 7% to 11% growth versus Adjusted EPS of $3.93 for 2023.
- Free cash flow of approximately $1.8 billion.
Revenue & Expenses
Visualization of income flow from segment revenue to net income